Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 497-504

  Park, Sun Young ^a   Jin, Mei Ling ^a   Kim, Younghun ^a   Lee, Sang Joon ^a   Park, Geuntae ^a  

^a Pusan National University   (South Korea)

Author keywords

COX 2; HO 1; Invasion; MMP 9; Sanguinarine; TPA

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROTEIN HO 1; PROTEIN KINASE B; SANGUINARINE; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR AP 1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL INVASION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION;

ANTI-INFECTIVE AGENTS; BENZOPHENANTHRIDINES; BREAST NEOPLASMS; CELL MOVEMENT; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEME OXYGENASE-1; HUMANS; ISOQUINOLINES; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA;

EID: 84891918413     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2843     Document Type: Article

References (22)

1. Love RR and Koroltchouk V: Tamoxifen therapy in breast cancer control worldwide. Bull World Health Organ 71: 795-803, 1993.
2. Agarwal R, Agarwal C, Ichikawa H, et al: Anticancer potential of silymarin: From bench to bed side. Anticancer Res 26: 4457-4498, 2006.
3. Gillard JA, Reed MW, Buttle D, et al: Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing. Wound Repair Regen 12: 295-304, 2004.
4. Jinga DC, Blidaru A, Condrea I, et al: MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors. J Cell Mol Med 10: 499-510, 2006.
5. Kim S, Kim SH, Hur SM, et al: Silibinin prevents TPA?induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. J Ethnopharmacol 126: 252-257, 2009.
6. Kim JH, Lee KW, Lee MW et al: Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-κB as a potential molecular target. FEBS Lett 580: 385-392, 2006.
7. Anand P, Sundaram C, Jhurani S, et al: Curcumin and cancer: an 'old-age? disease with an 'age-old? solution. Cancer Lett 267: 133-164, 2008.
8. Simeone AM, Nieves-Alicea R, McMurtry VC, et al: Cyclooxygenase-2 uses the protein kinase C/interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Int J Oncol 30: 785-792, 2007.
9. Otterbein LE and Choi AM: Heme oxygenase: Colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279: L1029-L1037, 2000.
10. Farombi EO and Surh YJ: Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 39: 479-491, 2006.
11. Jozkowicz A, Was H and Dulak J: Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9: 2099-2117, 2007.
12. Ye F, Feng F and Liu W: Alkaloids from Macleaya cordata. Zhongguo Zhong Yao Za Zhi 34: 1683-1686, 2009 (In Chinese).
13. Pang JX, Ma RQ, Liu LM, et al: Total alkaloid of Macleaya cordata: In vitro cytotoxic effect on Hep3B cells and in vivo antitumor effect in mice. Di Yi Jun Yi Da Xue Xue Bao 25: 325-328, 2005 (In Chinese).
14. Luo XB, Chen B and Yao SZ: Rapid determination of protopine, allocryptopine, sanguinarine and chelerythrine in fruits of Macleaya cordata by microwave-assisted solvent extraction and HPLC-ESI/MS. Phytochem Anal 17: 431-438, 2006.
15. Cornblatt BS, Ye L, Dinkova-Kostova AT, et al: Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28: 1485-1490, 2007.
16. Jang BC, Park JG, Song DK, et al: Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicol In Vitro 23: 281-287, 2009.
17. Kim S, Lee TJ, Leem J, Choi KS, et al: Sanguinarine-induced apoptosis: Generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J Cell Biochem 104: 895-907, 2008.
18. Johnson KD and Bresnick EH: Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. Methods 26: 27-36, 2002.
19. Simeone AM, McMurtry V, Nieves-Alicea R, et al: TIMP?2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells. Breast Cancer Res 10: R44, 2008.
20. Formenti S, Felix J, Salonga D, et al: Expression of metastases- associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. Clin Cancer Res 6: 4653-4657, 2000.
21. Larkins TL, Nowell M, Singh S and Sanford GL: Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6: 181, 2006.
22. Hill M, Pereira V, Chauveau C, et al: Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J 19: 1957-1968, 2005.